Science China Chemistry, Journal Year: 2024, Volume and Issue: unknown
Published: Oct. 21, 2024
Language: Английский
Science China Chemistry, Journal Year: 2024, Volume and Issue: unknown
Published: Oct. 21, 2024
Language: Английский
Science China Chemistry, Journal Year: 2025, Volume and Issue: unknown
Published: Feb. 19, 2025
Language: Английский
Citations
0Journal of Industrial and Engineering Chemistry, Journal Year: 2025, Volume and Issue: unknown
Published: March 1, 2025
Language: Английский
Citations
0Coordination Chemistry Reviews, Journal Year: 2025, Volume and Issue: 535, P. 216673 - 216673
Published: April 3, 2025
Language: Английский
Citations
0ACS Nano, Journal Year: 2025, Volume and Issue: unknown
Published: May 14, 2025
The lack of selective tumor targeting and the high toxicity conventional chemotherapy treatments remain major challenges in cancer therapy. Here, we develop a self-controlled DNA nanostructure-CRISPR-12a system, triple-locked cascade therapy nanocapsule (Tatna), for efficient targeted treatment. Tatna integrates structural tetrahedrons (DTs) with drug-loading capacity, Cas12a/crRNA ribonucleoprotein (Cas12a RNP), doxorubicin (DOX) to enable multisite response precise drug delivery augmented By incorporation nucleolin-targeting aptamer, achieves cell internalization. Encapsulation pH-responsive poly l-lactic-co-glycolic acid (PLGA) ensures stable circulation controlled release both DOX Cas12a until tumor-specific activation acidic microenvironment. RNP, triggered by APE1 mRNA overexpression cells, induces trans-cleavage DTs, releasing transport into nucleus induce enhanced apoptosis. This self-regulating multifunctional approach enhances efficacy while reducing off-target effects. Tatna's programmable, system represents powerful strategy advancing precision medicine personalized
Language: Английский
Citations
0ACS Applied Polymer Materials, Journal Year: 2025, Volume and Issue: unknown
Published: May 20, 2025
Language: Английский
Citations
0Advanced Science, Journal Year: 2024, Volume and Issue: unknown
Published: Nov. 26, 2024
Abstract Due to the inherent immunosuppression and immune evasion of cancer cells, combining photoimmunotherapy with checkpoint blockade leverages phototherapy enhancement, overcoming mutual limitations demonstrating significant anticancer potential. The main challenges include nonspecific accumulation agents, uncontrolled activation, drug carrier safety. Smart DNA nanospheres (NS) is developed targeted delivery controllable release photosensitizers agents achieve effective synergistic therapy minimize side effects. multifunctional NS incorporate a targeting module for programming aptamers, response i‐motif DNA/RNA hybrid sequences, therapeutic packaging PD‐L1 siRNA. navigate tumor site are sequentially activated by intracellular acid enzymes programmed death ligand 1 (PD‐L1) small interfering RNA (siRNA). Besides killing promotion, downregulate expression, alleviating tolerance evasion, thus enhancing response. These results indicate that significantly enhance antitumor responses, synergistically improve efficacy, reduce systemic toxicity. This study broadens application nanomaterials in precision therapy.
Language: Английский
Citations
1Science China Chemistry, Journal Year: 2024, Volume and Issue: unknown
Published: Oct. 21, 2024
Language: Английский
Citations
0